Friday, 13 May 2016

AYUSH Ministry rails against global study on homeopathy

COMMENT (24)   ·   PRINT   ·   T  T  
According the AYUSH Ministry the study on homeopathy by National Health and Medical Research Council, Australia’s top medical research organisation, “have drawn criticism for its unscientific approach and methodological shortcomings”. File photo
The Hindu
According the AYUSH Ministry the study on homeopathy by National Health and Medical Research Council, Australia’s top medical research organisation, “have drawn criticism for its unscientific approach and methodological shortcomings”. File photo

Australia's top medical research body‘s “findings are contrary to findings and conclusions of homeopathy in India", the AYUSH Ministry told the Lok Sabha.

A year after Australia’s top medical research organisation, the National Health and Medical Research Council (NHMRC), debunked homeopathy is no more effective than a placebo, the Ministry of AYUSH (Ayurveda, Yoga, Unani, Siddha & Homeopathy) has criticised the most extensive, global study on the subject for using an “unscientific approach” and stated that the findings are contrary to conclusions reached in India.
Answering a question on whether the AYUSH Ministry taken note of the Australian study, AYUSH Minister Shripad Yesso Naik said in the Lok Sabha that, “NHMRC had not taken up any study on effectiveness of homeopathy.” He added that the NHMRC had studied a “small number of already published papers and reached conclusions. The observations of the NHMRC have drawn criticism for its unscientific approach and methodological shortcomings”.
The NHMRC study was the first of its kind to thoroughly review 225 research papers on homeopathy before coming up with a position statement in March 2015. Further, the researchers had reviewed evidence of 176 trials, focussed on 68 different health conditions, and conducted a total of 57 systematic reviews to establish if the treatment is valid. The NHMRC had concluded that there was no evidence that homeopathy was more effective than placebo on any of the conditions.
“Based on the assessment of the evidence of effectiveness of homeopathy, NHMRC concludes that there are no health conditions for which there is reliable evidence that homeopathy is effective,” the report concluded. Chair of the NHMRC Homeopathy Working Committee, Professor Paul Glasziou had said that, “people who choose homeopathy may put their health at risk if they reject or delay treatments for which there is good evidence for safety and effectiveness.”
While the AYUSH Minister did not clarify how the NHMRC study had methodological shortcomings, his defence of the branch of medicine was that the “findings are contrary to findings and conclusions of homeopathy in India”.
The AYUSH Ministry will shortly be piloting a programme called ‘homeopathy for a healthy child’ in five districts in Delhi, Kamrup (Assam), Palghar (Maharashtra), Noida (Uttar Pradesh) and Gorakhpur (Uttar Pradesh). The programme will mainly focus on dental problems in children between the ages of one and 18.

St. Louis jury awards $55M in Johnson & Johnson cancer suit

  • PTI
COMMENT (1)   ·   PRINT   ·   T  T  
A bottle of Johnson and Johnson Baby Powder is seen in a photo illustration taken in New York, February 24, 2016. Consumers expressed concern on social media about a talc-based baby powder made by Johnson & Johnson on Wednesday after a Missouri jury ordered the company to pay $72 million in damages to the family of a woman who said her death from cancer was linked to use of the product.
Reuters
A bottle of Johnson and Johnson Baby Powder is seen in a photo illustration taken in New York, February 24, 2016. Consumers expressed concern on social media about a talc-based baby powder made by Johnson & Johnson on Wednesday after a Missouri jury ordered the company to pay $72 million in damages to the family of a woman who said her death from cancer was linked to use of the product.

"The evidence is real clear that Johnson & Johnson has known about the dangers associated with talcum powder for over 30 years," Mr. Onder said.

For the second time in three months, a St. Louis jury has ordered Johnson & Johnson to pay a huge award over claims that its talcum powder causes cancer.
The jury deliberated eight hours on Monday before ordering the company to pay $ 55 million to a South Dakota woman who blamed her ovarian cancer on years of talcum powder use.
In February, another St. Louis jury awarded $ 72 million to the family of an Alabama woman who died from ovarian cancer, which she said was caused by using Johnson & Johnson’s baby powder and other talcum products.
New Jersey—based Johnson & Johnson will appeal the latest ruling.
“Unfortunately, the jury’s decision goes against 30 years of studies by medical experts around the world that continue to support the safety of cosmetic talc,” Johnson & Johnson spokeswoman Carol Goodrich said in a statement.
“For over 100 years, Johnson & Johnson has provided consumers with a safe choice for cosmetic powder products and we will continue to work hard to exceed consumer expectations and evolving product preferences.”
But Jim Onder, attorney for the plaintiff, Gloria Ristesund, said researchers began linking talcum powder to ovarian cancer in the 1970s, and he said internal Johnson & Johnson documents showed that the company was aware of those studies.
“The evidence is real clear that Johnson & Johnson has known about the dangers associated with talcum powder for over 30 years,” Mr. Onder said. “Instead of giving a warning, what they did was targeted the groups most at risk for developing ovarian cancer,” specifically marketing to overweight women, he said.
Talc is naturally occurring, mined from the soil and composed of magnesium, silicon, oxygen, and hydrogen. It’s widely used in cosmetics and personal care products, such as talcum powder, to absorb moisture, prevent caking and improve the product’s feel.
In February, a St. Louis jury awarded $72 million to the family of Jackie Fox of Birmingham, Alabama. Her son took over as plaintiff after his mother death in October at age 62.
She had used the talcum powder for decades.
Johnson & Johnson faces at least 1,200 still-pending talcum powder lawsuits, including about 1,000 in St. Louis and 200 in New Jersey, Mr. Onder said.
Johnson & Johnson previously has been targeted by health and consumer groups over possibly harmful ingredients in items including its iconic Johnson’s No More Tears baby shampoo.

Excess pregnancy weight gain may make your child obese

  • PTI
COMMENT   ·   PRINT   ·   T  T  
Children of mothers who had elevated blood sugar during pregnancy were at higher risk for childhood obesity. File photo
AP
Children of mothers who had elevated blood sugar during pregnancy were at higher risk for childhood obesity. File photo

Mothers-to-be, take note! Excess weight gain and elevated blood sugar levels during their pregnancy may put your babies at risk of becoming overweight or obese during the first decade of their life, a new study has found.
The study, which followed more than 24,000 mothers and their children over 10 years, is the largest to date on the topic and the first to show that these pregnancy risk factors increase the likelihood of childhood obesity even in babies who are normal weight (2.4 to 3.9 kg) at birth.
All of the mothers gave birth to normal weight babies between 1995 and 2003. The researchers matched the mothers’ medical records with their children’s records, and followed the children from ages 2 to 10.
Previous studies have shown that excess weight gain and elevated blood sugar during pregnancy increase a woman’s risk of delivering a large baby who is more likely to become an obese child.
However, there was not much evidence that these risk factors also affected normal-weight babies, researchers said.
“When women have elevated blood sugar and gain excess weight during pregnancy, it seems to change the baby’s metabolism to ‘imprint’ the baby for childhood obesity,” said lead author Teresa Hillier, senior investigator at the Kaiser Permanente Centre for Health Research in U.S.
“We’re not sure yet of the exact mechanism of this change, but it appears the baby is adapting to an overfed environment, whether from glucose or extra weight,” said Hillier.
Children of mothers who had elevated blood sugar during pregnancy were at higher risk for childhood obesity, but those whose mothers had gestational diabetes — the highest level of elevated blood sugar — were at the greatest increased risk.
Those children were at least 30 per cent more likely to be overweight or obese between the ages of 2 and 10, compared to children whose mothers had normal blood sugar.
Children of mothers who gained about 18 kg or more during pregnancy were at least 15 per cent more likely to be overweight or obese between the ages of 2 and 10, compared to children whose mothers gained less than 18 kg.
Many other behavioural and environmental factors contribute to childhood obesity, including the baby not being breastfed, a child’s poor eating and exercise habits, and lack of access to healthy foods and safe areas to play, researchers said.
The study shows that the effect in the womb on the baby’s metabolism may be as important as what happens after the child is born.
“We can’t wait until the baby is born to determine and address the impact on childhood obesity,” said Hillier.
“We need to intervene during the mom’s pregnancy to help her with nutritional and lifestyle changes that will result in healthy weight gain, healthy blood sugar and ultimately, healthy children,” she said.
The study was published in the Maternal and Child Health Journal.

SDGs: big agenda, big opportunities for India

COMMENT (1)   ·   PRINT   ·   T  T  
Awareness: Cardiovascular diseases, cancer, respiratory diseases and diabetes are the big four NCDs. Photo: K. Gajendran.
THE HINDU
Awareness: Cardiovascular diseases, cancer, respiratory diseases and diabetes are the big four NCDs. Photo: K. Gajendran.

The year 2016 marks an end of the era of Millennium Development Goals (MDGs), which drove the global development agenda since the new millennium. The MDGs have paved the way for Sustainable Development Goals (SDGs) that the world will strive to achieve over the next fifteen years. It is an opportune moment to reflect on the successes and the lessons learnt from the MDG era and the possible way forward for achieving the ambitious and inclusive agenda of SDGs in the health sector.
Lessons learnt
First, high-level political commitment globally and nationally drove much of the progress towards MDGs. We need nothing less for the SDGs. Second, while MDGs helped improve the overall health of nations, the focus was on the aggregate targets ignoring inequities within countries. To understand the real progress and challenges there is a need to disaggregate data by gender, economic status and geographical area. Thirdly, neither the economic benefits of good health nor the direct financial consequences of ill-health were sufficiently captured by MDGs. We know that nations require a healthy population to prosper. When people do fall sick, high out-of-pocket expenditures on healthcare lead to financial hardship and diminish the ability of the population to contribute to the economy. In India, nearly 60 million people fall into poverty just paying for healthcare, while many more abstain or delay seeking healthcare due to financial difficulties.
Fourthly, MDGs did not capture the importance of prevention, early detection and response to disease threats. The growing noncommunicable disease (NCD) epidemic and consequent premature deaths could be prevented by reducing lifestyle risk factors, specifically tobacco use, food intake, inactivity, and alcohol consumption. In addition, diseases like SARS, Ebola, MERS and Zika pose threats to global health security and have the potential to cripple countries. MDGs missed this important issue.
Lastly, it is not only about ‘more money for health, but also more health for money’; the MDGs focused on addressing specific disease and symptoms, which led to fragmentation, duplication and inefficiencies in the health systems. WHO estimates that nearly 20-40 per cent of all health resources are wasted.
The way forward
Unlike MDGs, which had three dedicated health goals, the SDG agenda has only one health goal (SDG-3) which aims to ‘ensure healthy lives and promote well-being for all in all ages’. The 13 broad targets under health goal are in-tune with current global epidemiological reality. Besides the unfinished MDG agenda of reducing maternal and child mortality and tackling the communicable disease, the SDG-3 also aims to tackle the epidemic of NCDs, substance abuse and ill-effects of environmental hazards. Health is also interlinked to several other SDGs related to poverty, gender equality, education, food security, water sanitation etc.
The unprecedented scope of SDGs provides immense opportunity to bring health at the centre of economic growth agenda, which is PM Modi’s topmost priority. Universal Health Coverage (UHC), which is an explicit target under SDG-3, can act as the anchor to guide and inform SDG goals in health.
It is interesting that these thoughts have their roots in what was envisioned by Mahatma Gandhi. He said, “Recall the face of the poorest and weakest man you have seen, and ask yourself if this step you contemplate is going to be any use to him.” It is this thinking, which was reflected in the MDGs and is now even more central in the SDGs.
Towards sustainable development
India can progress towards sustainable development in health if it follows the following five steps.
First, health must be high on the national and state agenda, as it is the cornerstone for economic growth of the nation. This requires high political commitment and collective long-term efforts by ministries beyond the Ministry of Health to invest in health. The proposal in India’s draft National Health Policy 2015 to raise public to health expenditure to 2.5 per cent of the GDP by 2020 is commendable.
Second, India should invest in public health and finish the MDG agenda through further improvements in maternal and child health, confronting neglected tropical diseases, eliminating malaria, and increasing the fight against tuberculosis. For all these challenges, it is clear what needs to be done; programmes and interventions need to be taken to scale, with a central emphasis on equity and quality of services.
Third, accelerate the implementation of universal health coverage. UHC is important to prevent people slipping into poverty due to ill health and to ensure everyone in need has access to good quality health services. To complement tax revenue based health financing, incremental expansion of prepayment and risk pooling mechanisms such as Social Health Insurance are worth considering. UHC is at the core of SDGs and in the interest of people and governments.
Fourth, build robust health system in all aspects and strengthen both the rural and urban components, with comprehensive primary health care at its centre. Given the magnitude of the private sector in India, more effective engagement with private healthcare providers is vital. Appropriate contracting modality, which is an important feature under the Social Health Insurance or RSSY, can be worked out and private sector can be instrumental in complementing the public sector as demonstrated by different country experiences, including Thailand and Philippines.
Finally, develop a strong system for monitoring, evaluation and accountability. It is absolutely essential to regularly review and analyse the progress made for feeding into policy decisions and revising strategies based on the challenges.
In conclusion, the SDGs have the potential to create a world where no one is left behind.
The SDGS also make it possible to achieve what the WHO constitution mandates: attainment by all peoples of the highest possible level of health.
Henk Bekedam
(The author is the WHO Representative for India)